Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Aescin-Based Herbal Extracts for Managing Postoperative Sequelae Following Impacted Mandibular Third Molar Surgery
NCT07244029Recruiting
- Sponsor
- Oman Medical Specialty Board
- Start
- Jan 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of escin in postoperative pain and trismus (2 arms), sponsored by Oman Medical Specialty Board. Primary endpoint: Postoperative pain intensity at Day 7. Started Jan 2026; status: recruiting.
02
Drugs
escin
03
Conditions
postoperative paintrismus
Beyond the preview
Go deeper on NCT07244029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07244029.